Norinchukin Bank’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.13M | Sell |
9,834
-145
| -1% | -$98.7K | 0.06% | 175 |
|
|
2026
Q1 | $7.71M | Buy |
9,979
+347
| +4% | +$266K | 0.09% | 129 |
|
|
2025
Q4 | $7.43M | Buy |
9,632
+821
| +9% | +$558K | 0.09% | 131 |
|
|
2025
Q3 | $4.95M | Sell |
8,811
-343
| -4% | -$194K | 0.07% | 162 |
|
|
2025
Q2 | $4.81M | Buy |
9,154
+776
| +9% | +$433K | 0.07% | 166 |
|
|
2025
Q1 | $5.31M | Buy |
8,378
+2,568
| +44% | +$1.77M | 0.1% | 133 |
|
|
2024
Q4 | $4.14M | Buy |
5,810
+475
| +9% | +$399K | 0.09% | 137 |
|
|
2024
Q3 | $5.61M | Buy |
5,335
+732
| +16% | +$815K | 0.13% | 100 |
|
|
2024
Q2 | $4.84M | Buy |
4,603
+32
| +0.7% | +$31K | 0.14% | 95 |
|
|
2024
Q1 | $4.4M | Sell |
4,571
-136
| -3% | -$129K | 0.13% | 101 |
|
|
2023
Q4 | $4.13M | Sell |
4,707
-668
| -12% | -$550K | 0.1% | 107 |
|
|
2023
Q3 | $4.42M | Sell |
5,375
-5,610
| -51% | -$4.41M | 0.1% | 107 |
|
|
2023
Q2 | $7.89M | Buy |
10,985
+2,568
| +31% | +$1.98M | 0.13% | 117 |
|
|
2023
Q1 | $6.92M | Buy |
8,417
+221
| +3% | +$167K | 0.14% | 105 |
|
|
2022
Q4 | $5.91M | Sell |
8,196
-1,858
| -18% | -$1.37M | 0.13% | 116 |
|
|
2022
Q3 | $6.93M | Buy |
10,054
+977
| +11% | +$615K | 0.14% | 106 |
|
|
2022
Q2 | $5.37M | Sell |
9,077
-1,959
| -18% | -$1.27M | 0.11% | 122 |
|
|
2022
Q1 | $7.71M | Buy |
11,036
+1,065
| +11% | +$674K | 0.1% | 122 |
|
|
2021
Q4 | $6.3M | Sell |
9,971
-531
| -5% | -$326K | 0.08% | 132 |
|
|
2021
Q3 | $6.36M | Buy |
10,502
+616
| +6% | +$382K | 0.09% | 131 |
|
|
2021
Q2 | $5.52M | Buy |
9,886
+130
| +1% | +$65.9K | 0.08% | 132 |
|
|
2021
Q1 | $4.62M | Buy |
9,756
+465
| +5% | +$226K | 0.06% | 142 |
|
|
2020
Q4 | $4.49M | Sell |
9,291
-11
| -0.1% | -$5.94K | 0.06% | 137 |
|
|
2020
Q3 | $5.21M | Buy |
9,302
+609
| +7% | +$369K | 0.08% | 119 |
|
|
2020
Q2 | $5.42M | Buy |
8,693
+1,643
| +23% | +$933K | 0.09% | 108 |
|
|
2020
Q1 | $3.44M | Sell |
7,050
-3,853
| -35% | -$1.59M | 0.07% | 136 |
|
|
2019
Q4 | $4.09M | Sell |
10,903
-875
| -7% | -$294K | 0.05% | 191 |
|
|
2019
Q3 | $3.27M | Buy |
11,778
+418
| +4% | +$124K | 0.05% | 244 |
|
|
2019
Q2 | $3.56M | Sell |
11,360
-3,821
| -25% | -$1.27M | 0.05% | 217 |
|
|
2019
Q1 | $6.23M | Buy |
15,181
+701
| +5% | +$289K | 0.08% | 164 |
|
|
2018
Q4 | $5.41M | Buy |
14,480
+4,514
| +45% | +$1.65M | 0.08% | 167 |
|
|
2018
Q3 | $4.03M | Buy |
9,966
+1,202
| +14% | +$457K | 0.05% | 184 |
|
|
2018
Q2 | $3.02M | Buy |
8,764
+1,688
| +24% | +$528K | 0.05% | 199 |
|
|
2018
Q1 | $2.44M | Buy |
7,076
+916
| +15% | +$319K | 0.04% | 207 |
|
|
2017
Q4 | $2.32M | Buy |
6,160
+441
| +8% | +$179K | 0.04% | 206 |
|
|
2017
Q3 | $2.56M | Buy |
5,719
+431
| +8% | +$205K | 0.05% | 210 |
|
|
2017
Q2 | $2.6M | Buy |
5,288
+346
| +7% | +$151K | 0.05% | 191 |
|
|
2017
Q1 | $1.92M | Buy |
4,942
+355
| +8% | +$132K | 0.04% | 240 |
|
|
2016
Q4 | $1.68M | Buy |
4,587
+545
| +13% | +$207K | 0.04% | 244 |
|
|
2016
Q3 | $1.63M | Sell |
4,042
-49
| -1% | -$19.7K | 0.04% | 242 |
|
|
2016
Q2 | $1.43M | Buy |
4,091
+84
| +2% | +$32.4K | 0.03% | 248 |
|
|
2016
Q1 | $1.44M | Buy |
4,007
+380
| +10% | +$157K | 0.04% | 245 |
|
|
2015
Q4 | $1.97M | Sell |
3,627
-797
| -18% | -$432K | 0.05% | 187 |
|
|
2015
Q3 | $2.06M | Buy |
4,424
+156
| +4% | +$83.8K | 0.05% | 195 |
|
|
2015
Q2 | $2.18M | Sell |
4,268
-105
| -2% | -$51.2K | 0.06% | 195 |
|
|
2015
Q1 | $1.97M | Hold |
4,373
| – | – | 0.05% | 215 |
|
|
2014
Q4 | $1.79M | Buy |
4,373
+1,411
| +48% | +$555K | 0.04% | 215 |
|
|
2014
Q3 | $1.07M | Sell |
2,962
-11
| -0.4% | -$3.69K | 0.03% | 208 |
|
|
2014
Q2 | $840K | Sell |
2,973
-285
| -9% | -$84.5K | 0.02% | 218 |
|
|
2014
Q1 | $978K | Buy |
3,258
+324
| +11% | +$99.8K | 0.03% | 208 |
|
|
2013
Q4 | $808K | Buy |
2,934
+4
| +0.1% | +$1.15K | 0.02% | 221 |
|
|
2013
Q3 | $917K | Buy |
2,930
+284
| +11% | +$74.7K | 0.03% | 187 |
|
|
2013
Q2 | $595K | Buy |
+2,646
| New | +$616K | 0.02% | 227 |
|
Other funds holding REGN
Norinchukin Bank's REGN Position: Q2 2026 in Review
Norinchukin Bank reduced its Regeneron Pharmaceuticals (REGN) stake by 1.5% in Q2 2026, selling an estimated $98.7K and leaving 9,834 shares worth $6.13M. The position accounts for 0.06% of the portfolio, ranked #175.
Norinchukin Bank first reported a position in REGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $7.89M in Q2 2023. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Norinchukin Bank held 9,834 shares of Regeneron Pharmaceuticals worth $6.13M as of Q2 2026.
- Norinchukin Bank sold 145 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $98.7K.
- Regeneron Pharmaceuticals made up 0.06% of Norinchukin Bank's portfolio in Q2 2026, its #175 holding.
- Norinchukin Bank first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- Norinchukin Bank's Regeneron Pharmaceuticals position peaked at $7.89M in Q2 2023.
- 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Norinchukin Bank's 13F filing for Q2 2026, filed 14 Aug 2026.